HER2/positive and HER2/low in inflammatory breast cancer recurrence.
Movchan OV, Bagmut IY, Shipko AF, Smolanka Senior II, Sheremet MI, Kolisnyk IL, Bagmut OV, Lyashenko AO, Loboda AD, Ivankova OM, Dosenko IV, Lazaruk OV, Gyrla YV, Bilookyi OV.
Movchan OV, et al. Among authors: loboda ad.
J Med Life. 2022 Dec;15(12):1573-1578. doi: 10.25122/jml-2022-0213.
J Med Life. 2022.
PMID: 36762329
Free PMC article.